Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesco Berti
Observed institutions:
GlaxoSmithKline (United Kingdom),
Novartis (Italy)
ORCID:
0000-0002-6493-6516
Observed ORCID:
0000-0002-6493-6516
OpenAlex ID:
A5101957512
Towards the next generation of biomedicines by site-selective conjugation
2016
·
Qi-Ying Hu
, Francesco Berti
, et al.
·
Chemical Society Reviews
·
167
PDF
Synthetically defined glycoprotein vaccines: current status and future directions
2013
·
Roberto Adamo
, Alberto Nilo
, et al.
·
Chemical Science
·
159
PDF
Synthesis of a well-defined glycoconjugate vaccine by a tyrosine-selective conjugation strategy
2013
·
Qi-Ying Hu
, Martin Allan
, et al.
·
Chemical Science
·
123
Antimicrobial glycoconjugate vaccines: an overview of classic and modern approaches for protein modification
2018
·
Francesco Berti
, Roberto Adamo
·
Chemical Society Reviews
·
114
PDF
Deciphering the structure–immunogenicity relationship of anti- Candida glycoconjugate vaccines
2014
·
Roberto Adamo
, Qi-Ying Hu
, et al.
·
Chemical Science
·
64
PDF
Defined Conjugation of Glycans to the Lysines of CRM 197 Guided by their Reactivity Mapping
2014
·
Stefano Crotti
, Huili Zhai
, et al.
·
ChemBioChem
·
63
Classical- and bioconjugate vaccines: comparison of the structural properties and immunological response
2022
·
Maria R Romano
, Francesco Berti
, et al.
·
Current Opinion in Immunology
·
23
Orthogonal cleavage of the 2-naphthylmethyl group in the presence of the p-methoxy phenyl-protected anomeric position and its use in carbohydrate synthesis
2016
·
Vittorio Cattaneo
, Davide Oldrini
, et al.
·
Organic Chemistry Frontiers
·
21
In memory of Paolo Costantino (1955–2020)
2021
·
Francesco Berti
, Roberto Adamo
·
Glycoconjugate Journal
PDF
Show more works
View as search
Works count:
9
Citation count:
734
H-index:
8
I10-index:
8
Year
Topic
Type